Big Pharma, clocks and clinics converge at 7th TimePie Forum

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

TimePie’s Hebe Chen spotlights key developments from Shanghai, from therapeutic targets to China’s expanding clinical longevity footprint.

A biological clock that measures the pace of aging, a drug being tested for age-related conditions, a biotech company developing new therapies, and a clinic offering longevity-focused care. These seemingly different efforts came together at the 7th TimePie Longevity Forum, which brought around 3,000 participants to Shanghai in September 2026.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Guest Contributor

A guest contributor joins us to add to the longevity conversation!

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE